# Cold Sore Fever Blister Treatment

NDC: 68016-344
Generic name: Docosanol
Labeler / Manufacturer: Chain Drug Consortium, LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CREAM
Routes: TOPICAL
Marketing started: 20210601
Marketing ended: 20261231
FDA application: ANDA208754

## Active ingredients

- DOCOSANOL: 100 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68016-344"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68016-344
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86406372-9e95-43b9-b275-5661141a085b